Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
07 04 2023
Historique:
received: 10 03 2023
revised: 30 03 2023
accepted: 05 04 2023
medline: 17 5 2023
pubmed: 16 5 2023
entrez: 16 5 2023
Statut: epublish

Résumé

Clear cell renal cell carcinoma (ccRCC) accounts for ~75% of kidney cancers. The biallelic inactivation of the von Hippel-Lindau tumor suppressor gene (

Identifiants

pubmed: 37190010
pii: cells12081102
doi: 10.3390/cells12081102
pmc: PMC10136813
pii:
doi:

Substances chimiques

Nucleosides 0
Von Hippel-Lindau Tumor Suppressor Protein EC 2.3.2.27
RNA 63231-63-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Nucleic Acids Res. 2009 Jul;37(Web Server issue):W652-60
pubmed: 19429898
Nucleic Acids Res. 2010 Apr;38(7):2387-98
pubmed: 20047967
Wiley Interdiscip Rev Syst Biol Med. 2010 Sep-Oct;2(5):594-602
pubmed: 20836050
Pathology. 2010 Jun;42(4):374-83
pubmed: 20438412
Nucleic Acids Res. 2016 May 5;44(8):e71
pubmed: 26704973
Nat Commun. 2019 Dec 5;10(1):5542
pubmed: 31804502
J Clin Invest. 2013 Sep;123(9):3664-71
pubmed: 23999440
Anal Bioanal Chem. 2019 Sep;411(24):6319-6328
pubmed: 31037374
DNA Cell Biol. 2012 May;31(5):660-71
pubmed: 22136356
J Biol Chem. 2017 Sep 1;292(35):14695-14703
pubmed: 28655767
Nucleic Acids Res. 2022 Jan 7;50(D1):D231-D235
pubmed: 34893873
Anal Bioanal Chem. 2005 Jun;382(4):1017-26
pubmed: 15906010
J Am Soc Mass Spectrom. 2005 Jun;16(6):940-7
pubmed: 15907708
Sci Rep. 2015 Aug 21;5:13374
pubmed: 26293811
N Engl J Med. 2016 Sep 22;375(12):1109-12
pubmed: 27653561
Nucleic Acids Res. 1994 Jun 25;22(12):2183-96
pubmed: 7518580
J Digit Imaging. 2013 Dec;26(6):1045-57
pubmed: 23884657
Cancer Metab. 2014 Feb 04;2(1):3
pubmed: 24491179
Mol Cell Biochem. 2021 Dec;476(12):4493-4505
pubmed: 34499322
Cancer Cell. 2016 Jan 11;29(1):104-116
pubmed: 26766592
BMC Biochem. 2007 Nov 29;8:25
pubmed: 18047657
Anal Bioanal Chem. 2015 May;407(13):3555-66
pubmed: 25736241
Mol Cell. 2010 Mar 12;37(5):597-606
pubmed: 20227365
Nucleic Acids Res. 2023 Jan 6;51(D1):D523-D531
pubmed: 36408920
Acta Oncol. 1991;30(1):11-5
pubmed: 2009178
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14568-72
pubmed: 20679243
Nat Rev Dis Primers. 2017 Mar 09;3:17009
pubmed: 28276433
RNA Biol. 2017 Sep 2;14(9):1138-1152
pubmed: 27911188
BMC Genomics. 2006 Jun 08;7:142
pubmed: 16762068
Genes (Basel). 2019 Jan 30;10(2):
pubmed: 30704115
Biochemistry (Mosc). 2013 Dec;78(13):1392-404
pubmed: 24490730
Cell Metab. 2009 Apr;9(4):386-97
pubmed: 19356719
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Anal Chim Acta. 2008 Jun 16;618(1):29-34
pubmed: 18501242
Nat Commun. 2020 Aug 17;11(1):4111
pubmed: 32807776
Nat Med. 2017 Jul;23(7):869-877
pubmed: 28553932
Semin Cancer Biol. 2019 Apr;55:8-15
pubmed: 30055950
Front Immunol. 2022 Mar 14;13:859893
pubmed: 35359945
BMC Bioinformatics. 2009 May 27;10:161
pubmed: 19473525
Annu Rev Pathol. 2015;10:263-89
pubmed: 25387056
Cells. 2020 Jul 22;9(8):
pubmed: 32708015
Nat Rev Clin Oncol. 2020 Oct;17(10):611-629
pubmed: 32514148
Sci Rep. 2017 Nov 24;7(1):16272
pubmed: 29176719
Biomarkers. 2008 Jun;13(4):435-49
pubmed: 18484357
Nat Genet. 2013 Aug;45(8):860-7
pubmed: 23797736
Nature. 2013 Jul 4;499(7456):43-9
pubmed: 23792563
Biochemistry (Mosc). 2016 Sep;81(9):941-50
pubmed: 27682166
Cancer Cell Int. 2020 Jul 28;20:347
pubmed: 32742194
J Biol Chem. 2002 Jul 26;277(30):27256-64
pubmed: 12011058
JCI Insight. 2022 Dec 22;7(24):
pubmed: 36413415
Trends Pharmacol Sci. 2022 Jun;43(6):522-535
pubmed: 35461717
PLoS Genet. 2015 Oct 23;11(10):e1005620
pubmed: 26496356
Sci Rep. 2018 Jun 13;8(1):9022
pubmed: 29899363
Nucleic Acids Res. 2011 Jan;39(Database issue):D195-201
pubmed: 21071406
J Cancer Res Clin Oncol. 2020 Nov;146(11):2721-2730
pubmed: 32772231

Auteurs

Daniel A Mohl (DA)

Core Competence Metabolomics, Hilde-Mangold-Haus, University of Freiburg, 79104 Freiburg, Germany.
Institute of Organic Chemistry, University of Freiburg, 79104 Freiburg, Germany.

Simon Lagies (S)

Core Competence Metabolomics, Hilde-Mangold-Haus, University of Freiburg, 79104 Freiburg, Germany.
Institute of Organic Chemistry, University of Freiburg, 79104 Freiburg, Germany.
Institute of Medical Microbiology and Hygiene, Faculty of Medicine, Medical Center-University of Freiburg, 79104 Freiburg, Germany.

Kyra Zodel (K)

Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Centre-University of Freiburg, 79106 Freiburg, Germany.

Matthias Zumkeller (M)

Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Centre-University of Freiburg, 79106 Freiburg, Germany.

Asin Peighambari (A)

Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Centre-University of Freiburg, 79106 Freiburg, Germany.

Athina Ganner (A)

Renal Division, Department of Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Dietmar A Plattner (DA)

Institute of Organic Chemistry, University of Freiburg, 79104 Freiburg, Germany.

Elke Neumann-Haefelin (E)

Renal Division, Department of Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Mojca Adlesic (M)

Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Centre-University of Freiburg, 79106 Freiburg, Germany.

Ian J Frew (IJ)

Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Centre-University of Freiburg, 79106 Freiburg, Germany.
German Cancer Consortium (DKTK), Partner Site Freiburg, and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Signalling Research Centre BIOSS, University of Freiburg, 79104 Freiburg, Germany.
Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine and Medical Center-University of Freiburg, 79106 Freiburg, Germany.

Bernd Kammerer (B)

Core Competence Metabolomics, Hilde-Mangold-Haus, University of Freiburg, 79104 Freiburg, Germany.
Institute of Organic Chemistry, University of Freiburg, 79104 Freiburg, Germany.
Signalling Research Centre BIOSS, University of Freiburg, 79104 Freiburg, Germany.
Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, 79104 Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH